Breast cancer mortality trends in Peruvian women

[1]  H. Gómez,et al.  Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience , 2020, PloS one.

[2]  J. Sanz-Anquela,et al.  Geographic study of mortality due to mesothelioma in Peru and its evolution. , 2020, Cancer epidemiology.

[3]  C. la Vecchia,et al.  Cancer mortality predictions for 2019 in Latin America , 2019, International journal of cancer.

[4]  A. Hernández-Vásquez,et al.  Use of mammography in Peruvian women: An analysis of the 2018 Demographic and Health Survey. , 2019, Medwave.

[5]  C. la Vecchia,et al.  Trends and geographic pattern of stomach cancer mortality in Peru. , 2019, Cancer epidemiology.

[6]  C. Vallejos,et al.  Barriers in Latin America for the management of locally advanced breast cancer , 2019, Ecancermedicalscience.

[7]  T. Adair,et al.  Saving lives through certifying deaths: assessing the impact of two interventions to improve cause of death data in Perú , 2018, BMC Public Health.

[8]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[9]  H. Gómez,et al.  Breast cancer subtype and survival among Indigenous American women in Peru , 2018, PloS one.

[10]  G. Málaga,et al.  Geographic differences in overweight and obesity prevalence in Peruvian children, 2010–2015 , 2018, BMC Public Health.

[11]  C. la Vecchia,et al.  Trends and predictions to 2020 in breast cancer mortality: Americas and Australasia. , 2018, Breast.

[12]  V. Tsu,et al.  Model for Early Detection of Breast Cancer in Low-Resource Areas: The Experience in Peru , 2018, Journal of global oncology.

[13]  Eva Negri,et al.  Trends and predictions to 2020 in breast cancer mortality in Europe. , 2017, Breast.

[14]  H. Gómez,et al.  The implementation of the Plan Esperanza and response to the imPACT Review. , 2017, The Lancet. Oncology.

[15]  F. Bray,et al.  Cancer patterns, trends, and transitions in Peru: a regional perspective. , 2017, The Lancet. Oncology.

[16]  C. la Vecchia,et al.  Cancer mortality predictions for 2017 in Latin America , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  C. la Vecchia,et al.  European cancer mortality predictions for the year 2017, with focus on lung cancer , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  C. R. Mejía,et al.  Actitudes frente a la autoexploración de mama en dos facultades de ciencias de la salud de Ica, Perú: un estudio piloto , 2017, Salud publica de Mexico.

[19]  F. Cardoso,et al.  Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Nobhojit Roy,et al.  The Global Burden of Cancer 2013. , 2015, JAMA oncology.

[21]  S. Kaye,et al.  The neutrophil–lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials , 2015, British Journal of Cancer.

[22]  V. Beral,et al.  Trends in mortality from major cancers in the Americas: 1980-2010. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  E. Riboli,et al.  Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study , 2014, BMJ Open.

[24]  R. Baltussen,et al.  Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru , 2013, PloS one.

[25]  P. Marcom,et al.  Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort , 2013, Annals of Surgical Oncology.

[26]  B. Jönsson,et al.  A review of breast cancer care and outcomes in Latin America. , 2013, The oncologist.

[27]  Deepa Naishadham,et al.  Cancer statistics for Hispanics/Latinos, 2012 , 2012, CA: a cancer journal for clinicians.

[28]  H. Gómez,et al.  Breast cancer classification according to immunohistochemistry markers: subtypes and association with clinicopathologic variables in a peruvian hospital database. , 2010, Clinical breast cancer.

[29]  W. Goodson,et al.  Optimization of clinical breast examination. , 2010, The American journal of medicine.

[30]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.

[31]  Binbing Yu,et al.  Comparability of Segmented Line Regression Models , 2004, Biometrics.

[32]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[33]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[34]  Willy Ramos,et al.  Análisis de la situación del cáncer en el Perú, 2013 , 2013 .

[35]  Jennifer D. Brooks,et al.  Body mass index and risk of second primary breast cancer: The WECARE Study , 2011, Breast Cancer Research and Treatment.

[36]  Youngihn Kho,et al.  GeoDa: An Introduction to Spatial Data Analysis , 2006 .

[37]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[38]  Rafael Lozano,et al.  AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD , 2000 .